Consumer Spec - Pre Market Wrap
UBS Pushes Fed Easing to March 2027 | KDP Block Trade Pre (-), CASY F4Q Beat, BURL Evidence Lab Record Demand, NKE Bloomberg Stall, CHWY Downgrade, Evercore K-Economy Takeaways, MNST 2026 Top Pick
Consumer is light on incremental analyst reports but the sector has been trading well on a market that looks to diversify from AI/Semis trade. On today’s report BURL seems to be the most incrementally positive, UBS Evidence Lab flagging strongest demand reading in dataset history and ~33% PT upside as Burlington 2.0 finally clicks. NKE the painful counterweight, Bloomberg torching the Hill turnaround with shares -45% since October '24 and Adidas eating share at the World Cup. CHWY cut to Neutral at MoffettNathanson; KDP pressured as a holder dumps 59M shares at $31.10-31.70 — never love forced selling but Wells reiterates OW. CASY positive analyst notes after a fuel-margin beat, Wolfe to $1,069. MNST BofA's top pick on international inflection. UBS pushes Fed easing to March '27 — hawkish for rate-sensitive cohorts.
MACRO & MARKETS
MARKET: UBS PUSHES FED EASING CALL TO MARCH 2027 ON FIRM CORE INFLATION
UBS pushed back its Fed easing forecast to March 2027, with a second cut expected in June 2027 and the policy rate ultimately moving toward a 3.00-3.25% range. The firm expects the June FOMC to include “removal of the easing bias and a shift in the 2026 dot plot toward no cuts,” citing still-firm underlying inflation and a resilient labor market. May core CPI rose 0.21% MoM (vs 0.22% consensus), but core PCE tracking remains firmer at roughly 0.27% MoM (3.3% YoY), leaving the inflation signal “mixed rather than decisively weaker.” A positive: core goods disinflation re-emerged, providing “clear evidence that tariff pass-through effects are beginning to fade,” with tariff-related inflation projected to subtract 0.8ppt over the next year. Upside risks remain from Middle East energy/supply dynamics and AI-driven services demand. Read-through is incrementally hawkish for rate-sensitive consumer cohorts (homebuilders, autos, big-ticket discretionary retail).
MARKET: BOFA SAYS WORLD CUP IS ANOTHER TAILWIND FOR US GROWTH AND INFLATION PERSISTENCE
The firm frames the World Cup, which officially starts today, as a material near-term tailwind for the US economy. The analyst notes OpenEconomics estimates the tournament could add 0.6ppt to US GDP and 0.4ppt to World GDP, with some of the positive effects potentially already visible in the May jobs report. The upshot: another reason to expect US growth resilience and for inflation to remain “more persistent in the near-term.” Read-through is supportive for consumer-facing names with US exposure across travel/hospitality (cruises, hotels), restaurants, and packaged food/beverage tied to viewing occasions, while reinforcing the more hawkish near-term rate backdrop.
MARKETS: BTIG CALLS PULLBACK A POSITIONING UNWIND, NOT REGIME CHANGE
BTIG reads the SPX -4% pullback from the June 2 ATH of ~7609 to ~7300 as a positioning unwind, not a fundamental or regime shift, with semis/AI/high-beta sold and defensive/cyclical laggards covered; more turbulence expected, though unwinds without fundamental catalysts tend to be short-lived and the analyst doesn’t think this one has fully run its course. Key signpost is 50 DMA tests on QQQ/XLK/SOXX, where slope is rising sharply so downside diminishes daily, but the firm views the tests as likely with the reaction dictating whether a deeper correction is needed. High-beta vs low-vol ratio is flagged as the same signal as high vs low momentum, watching for mean reversion back to its 50 DMA. Constructive on laggards with HC, Financials, and REITs cited as better setups; Insurance names AIZ, AFL, ALL, MET called out as trying to break out of multi-year consolidations (none rated).
CONSUMER STREET RESEARCH
Upgrades
No upgrades in consumer sector today
Downgrades
Chewy (CHWY) Cut to Neutral at MoffettNathanson; PT $22
Initiations
Callaway Golf (CALY) Assumed Neutral at Goldman Sachs; PT $17
EARNINGS REPORTS
No reports in the covered consumer names today
ANALYST RESEARCH & NEWS
NKE: SUBJECT OF NEGATIVE BLOOMBERG ARTICLE, TURNAROUND UNDER CEO HILL APPEARS TO BE STALLING
Bloomberg notes the stock is down >45% since Hill’s October 2024 return, erasing ~$57bn in market cap and trading near a decade low, while global sports footwear share has fallen to ~19% (vs. ~24% in 2016, per Euromonitor) as Skechers, New Balance, On, and Hoka take ground. The article flags most recent quarter revenue roughly flat Y/Y and down ~10% from two years ago, with Greater China expected to drop ~20%, Converse -35%, DTC -4%, GM compressed to ~40% from ~45% two years prior, and sportswear posting a DD% decline; F4Q prints June 30. World Cup execution has been messy, with puckering on Nike-branded jerseys, production delays leaving only ~60% of planned March-launch inventory at retail versus a ~98% target, and a pulled Boston Marathon ad, while Adidas (roughly half NKE’s size) saw revenue +20% over the same window, captured the sub-2-hour barrier at London Marathon with a $500 shoe, and is outfitting 14 WC teams to NKE’s 12. BI consumer work still shows NKE as the top planned sneaker purchase across income levels (Gilmartin/Goyal frame the issue as execution rather than brand loyalty), with a fall analyst/investor day on campus the next material catalyst; 1,400 layoffs announced this spring and no clear internal successor to Hill identified after the departures of O’Neill and Williams.
COCO: EVERCORE HOSTS CEO, REITERATES OUTPERFORM, $75 PT, FLAGS MULTIYEAR GROWTH RUNWAY
Meetings with CEO Martin Roper at the firm’s NYC consumer conference reinforced a multiyear growth story domestically and internationally, with scanner data running >30% YTD and consumer pressure yet to bleed into the franchise. The analyst notes branded and PL coexist constructively given production, pricing, and retailer-mix differences; COCO is believed to be producing WMT’s recently launched “Great Value” tetra PL (on sale $1.00 vs. $1.18 normal, vs. Vita Coco 16.9oz at $2.27/$2.77), while Kirkland’s new premium PL ($2.47/14oz) targets Harmless Harvest and has replaced it on shelf in some stores. Gen Z consumption is accelerating tied to the “looksmaxxing” trend, international remains well below US per-capita (notably Western Europe), and management guided GM +~150 bps in FY26 despite headwinds from PL mix, international strength, and incremental production costs from higher-than-expected demand. Price pack architecture into both larger sizes (smoothie/heavy-user) and smaller sizes (immediate consumption) remains a meaningful unlock.
CONSUMER & RESTAURANTS: EVERCORE CONFERENCE TAKEAWAYS FLAG K-ECONOMY, GLP-1 IMPACT, BIG FOOD SHARE LOSSES
Wrapping food and restaurants meetings (MCD, SBUX, TXRH, EAT, DPZ, HSY, CPB, POST, BGS), the firm flags Big Food losing share to smaller brands while facing an energy-related inflation cliff that could push input cost inflation to MSD+ by 2027. Consumers are cutting calories at the expense of carb/sugar-dense categories and to the benefit of protein and energy beverages, with GLP-1s only part of that shift. The K-economy and “young generation recession” are real, with virtually all US restaurant demand growth concentrated in the 55+ cohort, while the analyst notes casual dining winners (TXRH, EAT, DRI) remain well-positioned on value perception and consumer mix though carry incremental commodity headwinds. For QSR, a strong specialty beverage program (SBUX, YUM, MCD) is increasingly essential to defend the drive-thru moat; absent that, execution on protein, value, marketing, and rapid menu news becomes critical.
MNST: BOFA REITERATES BUY, $99 PO, TOP PICK FOR 2026 ON INTERNATIONAL INFLECTION
The firm flags 1Q as a meaningful inflection with international now ~45% of revenue (43% TTM) versus 32% in 2019, putting MNST in line with PEP and PG and behind KO, CL, MDLZ, and PM. The analyst argues MNST deserves renewed multi-national consideration, with per-capita opportunity in Mexico, Brazil, India, and China as sustainable multi-year growth drivers; 1Q constant-currency growth in India, China, and Brazil was characterized as impressive, and EMEA/LatAm have driven growth for three consecutive quarters. Mature markets are not off limits either, with a recent win in Coca-Cola Japan’s vending channel (where MNST does not use the KO system exclusively) cited as evidence. Buy and $99 PO maintained.
KDP: WELLS FARGO REITERATES OW, $37 PT, TACTICAL LONG ON ACCELERATION
The firm reiterates OW with a $37 PT (16% upside), arguing stock at $31.70 and 12.6x CY27E EPS of $2.52 vs mid-teens fair value as Beverage accelerates and Coffee margin cycle turns, a three-legged thesis with no model change but a setup rarely this clean in Staples. The analyst flags Dr Pepper consumption +6% L4W (best since December), Canada Dry running best since Feb 2025 on Strawberry Fruit Splash, and Partners segment adding ~4ppt to growth via Bloom. SJM’s ~800bps margin upswing is cited as a leading proxy with implied cost relief potentially equaling ~45% of JDEP EBIT, flagged as upside optionality rather than base case. Valuation framework of 20x BevCo plus single-digit P/E for Coffee gets to the $37 PT; the firm says post-deal apathy following the April 1, 2026 JDEP close created the entry point with comps turning easiest in a year from here.
BURL: UBS EVIDENCE LAB SURVEY FLASHES STRONGEST DEMAND IN DATASET HISTORY, ~33% PT UPSIDE
The firm’s Evidence Lab survey shows the strongest demand reading in dataset history with Net Purchase Intent +26pp Y/Y to +24% (vs 14% survey average and -2% in Mar’25), and past-frequency traffic already running +17% in Mar’26, confirming forward intent is converting into actual store traffic. Consumer health signals are robust: 53% expect a net increase in apparel budgets (one of the strongest readings in the dataset), 62% say better off vs last year, 66% expect further improvement over NTM; value perception also improving with 33% better price perception and 46% net improvement in value-for-money, though the firm flags room to go further. The analyst sees brand awareness and loyalty (~19%) as the lag and the upside lever as Burlington 2.0 matures. UBS models 17% 5-yr EPS CAGR at 26x P/E and sees ~33% PT upside with EPS beats driving sell-side consensus revisions higher over the NTM.
LEVI: BOFA REITERATES BUY, $27 PT, SEES EARLY INNINGS OF EPS AND MULTIPLE UPSIDE
At 14x 27E P/E versus a 22x post-IPO high and 13x 5-yr average, the firm sees LEVI in early stages of a shift toward higher-quality, more consistent growth following the exit of lower-tier wholesale doors and lower-quality businesses, with the $27 PT based on 17x 27E. The analyst expects durable MSD%+ sales growth anchored by core denim bottoms (64% of sales, #1 global jeans share at 5.1%) plus underpenetrated tops and women’s running ahead of company average (tops +DD% in 2025, +13% in 1Q) and 15x TAM expansion as LEVI moves toward a 1:1 tops-to-bottoms mix vs. ~1:3 today; DTC is on track to 50% of sales in 2026E (vs. 36% in 2021), 2026 wholesale guide was raised to +LSD%, and China turned positive +8% in 1Q. Margin levers include distribution moving from 7% of sales toward 6% (US DC transition eliminates $5mn/qtr of parallel costs starting 2H26), mix-driven GM expansion of 30-40 bps/yr, and 80% global assortment commonality by 1H27 vs. ~50% today, supporting EBIT margin to ~13% by 2028E vs. an internal 15% long-term target. The RL parallel underpins the multiple-expansion case, though the analyst adds RL’s premium has been earned via faster sales growth and a wider EBIT margin gap.
CHEF: BTIG REITERATES BUY, RAISES PT TO $100 AFTER MANAGEMENT MEETINGS
Following a full day with CEO Pappas, CFO Leddy, and Treasurer Carter in Boston, the firm expects CHEF to hit its 2028 targets early on robust sales trends despite Middle East conflict, with management eyeing a path to $10B in revenue vs. ~$4.15B in 2025 via consistent organic growth and tuck-ins. The analyst notes the core business already runs at ~10% EBITDA margin (nearly 400 bps above consolidated) and that AI is driving efficiency across procurement, pricing, inventory, hiring, and salesforce training, with management characterizing margin expansion as in early innings. Tuck-ins are possible in nearly every market but a transformational deal is unlikely; mid-Atlantic geographic expansion and incremental Middle East investment are expected, with net leverage held at 2.0x-2.5x (1.9x today). The $100 PT reflects 14.0x EV/EBITDA on 2027E EBITDA of $325.6MM, a ~3.0x premium to the 3-yr historical average.
CASY: WOLFE AND BMO RAISE PTS TO $1,069 AND $950 AFTER F4Q26 FUEL-DRIVEN BEAT
Two brokers raised targets following Casey’s exceptionally strong F4Q26 print (April end), driven by significant fuel margin upside and accelerating inside same-store sales. F4Q gross profit grew 17% to $1,080M vs consensus at $1,001M, EBITDA of $350M beat $304M consensus, and EPS of $4.37 beat $3.31. Inside SSS rose 5.5% vs 4.4% consensus (though decelerating 50bps on a 2-year basis), with Prepared Food and Beverage up 6.6% and Grocery/Merch up 5.1%; inside gross margins expanded 120bps to 42.4% on improved waste and mix. Fuel margins jumped 9.3c YoY to 46.9c vs 39.4c consensus and management’s prior low-40s commentary; same-store fuel volumes were up 1.5% (vs 0.4% prior quarter) with net gallons up 3.6%, suggesting continued share gains. Bull case (Wolfe, PT to $1,069 from $808, Outperform): F1Q27 fuel margins appear off to an equally strong start, opex leverage remains intact (same-store opex ex-credit card fees up 3.6%, labor hours roughly flat), and Casey’s has reduced same-store labor hours 5% over the last three-year plan. Bear/neutral case (BMO, PT to $950, Market Perform): the firm models 8-10% EBITDA growth in F27E in line with guidance off a higher F26 base, viewing core updates as encouraging but holding Market Perform as valuation stretches to 40x P/E or 21x EV/EBITDA (from 35x/18x).
CROX: STIFEL REITERATES HOLD WITH $105 PT AHEAD OF MANAGEMENT MEETINGS
The firm reiterated a Hold rating and $105 PT ahead of upcoming management meetings, framing valuation as the compelling setup. The analyst notes shares trade at 7.2x EV/EBITDA even after significant May outperformance, a 3.2x turn discount to the lifestyle footwear peer median at 10.4x. The firm says visibility into the core North America business had been clouded by a mid-2Q25 strategy shift toward “quality of sales over revenue growth,” and lapping that dynamic now provides a cleaner read on underlying domestic trajectory. The analyst adds the meetings will focus on drivers supporting the durability of growth, particularly in North America where investor focus is most acute, with valuation to be reassessed post-meetings.
CALY: GOLDMAN SACHS ASSUMES COVERAGE AT NEUTRAL WITH $17 PT POST-TOPGOLF DIVESTITURE
The firm assumes coverage on Callaway Golf at Neutral with a 12-month $17 PT, framing the company as better-positioned following the Topgolf divestiture to focus on its pure-play golf business but flagging execution risk and limited visibility into share gains at this early stage. The analyst notes regaining market share among both novice and experienced players is the key driver behind the stock, with Callaway having been a “net share donor during the Topgolf years.” Strong sales growth in Clubs and green-grass share progress in Balls during the first quarter without Topgolf is encouraging, but deferred 2H innovation cadence and competitor brands gaining ground on Morning Consult net favorability suggest future gains will be hard fought. The firm adds that although golf participation has largely held onto its COVID-era gains, evidence of slowing growth off those levels will only further intensify competition.
KDP -2%...a large holder is selling 59.1 million shares of beverage maker Keurig Dr Pepper Inc. in an unregistered block trade marketed for $31.10 to $31.70 per share, according to people familiar with the matter (Bloomberg).
Thanks for reading! If you enjoyed Consumer Spec, we’d appreciate you sharing it.
EARNINGS CALENDAR
